Related Experiment Video
Updated: Jun 5, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
[Anti-inflammatory and immune modulation therapy against atherosclerosis]
Tomoya Yamashita1, Ken-Ichi Hirata
1Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine.
Abstract:
Atherosclerosis is a chronic inflammatory disease and many kinds of inflammatory cells and their releasing molecules are profoundly associated with the initiation and progression of the disease. However, we never have clinical therapeutic methods to directly intervene the inflammation or to modulate the immune system for preventing atherosclerosis so far. This article will focus on the recent experimental anti-inflammatory and immune modulatory therapies including active vaccination and induction of immune tolerance. We introduce our new experimental trial to develop a new immune therapy against atherosclerosis. We hope some novel therapies could be applied to clinics in the near future.
Related Concept Videos
Atherosclerosis III: Management
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammation
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Atherosclerosis IV: Nursing Management